Recurrent or Metastatic NPC
3 clinical trials · Condition
◉ Watch Recurrent or Metastatic NPC
| Record | Firm | Date |
|---|---|---|
| NPC - AXEL Study : Axitinib-Avelumab (NCT04562441) | Chinese University of Hong Kong | 2021-05-06 |
| The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer (NCT03581786) | Shanghai Junshi Bioscience Co., Ltd. | 2018-10-18 |
| Nasopharyngeal Carcinoma (NPC) Axitinib (NCT01249547) | Chinese University of Hong Kong | 2010-12-01 |
Track Recurrent or Metastatic NPC automatically
Every clearance here is in the API, with alerts when new ones post.